BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

OralDNA Labs Partners With the JP Institute for Clinical Education and Training


1/15/2009 10:57:20 AM

NASHVILLE, TN--(Marketwire - January 15, 2009) -

OralDNA Labs, Inc. (www.OralDNA.com), a specialty diagnostics company focused on bringing advanced laboratory testing to the dental community, today announced it has entered into an agreement to be the JP Institute's exclusive partner for diagnostic testing education.

Under the terms of this agreement, OralDNA and the JP Institute will conduct joint programs together throughout the United States in 2009, beginning with a program in Nashville, Tennessee on February 6-7, 2009.

"We are pleased to work with OralDNA Labs in communicating the importance of diagnostic testing in dentistry," said Jan Lazarus, co-founder of the JP Institute. "For the 30 past years, our JP Institute team has recognized the clinical impact of under-diagnosis of periodontal infections. Our team is extremely excited to finally have clinical lab tests that will improve the accuracy of diagnosis for these serious infectious diseases. This will allow Dentists, Hygienists and Periodontists to diagnose and treat these infections with the importance they deserve. We believe patient care can improve dramatically by using laboratory tests to identify the specific cause of infection and to predict the patients that often require more aggressive therapy."

"OralDNA is pleased to join with a high quality partner like the JP Institute," said Dr. Tom Nabors, chairman and Chief Dental Officer of OralDNA Labs. "We are excited that they see the value in diagnostic testing. Together we can continue to provide the right clinical training and follow-up for proper implementation. Jan and her team of trainers can help dental offices implement testing and integrate it into the overall office protocol for patient care."

About JP Institute (www.jpconsultants.com):

The JP Institute was founded in 1979 and is committed to developing and supporting clinical patient excellence and dental practice success. Through initiatives such as in-office training and consulting, Mastership Certification programs and hands-on training workshops, their curriculum supports both periodontal and restorative case acceptance. The JP Institute has been a leading force in helping dental practices achieve excellence by utilizing evidence-based therapies and integrating new products and technologies into comprehensive care.

For more information about The JP Institute please call 800-946-4944.

About OralDNA Labs, Inc. (www.OralDNA.com):

OralDNA Labs, Inc. is a specialty diagnostics company created to advance clinical testing in the dental community. Our goal is to help the dental profession achieve better clinical outcomes by providing reliable, definitive and cost effective clinical tests that drive the detection and prognosis of disease at an earlier, more treatable stage, with an initial focus on periodontal disease.

Periodontal disease is a bacterial infection that causes an inflammatory response. The disease is present in an estimated three quarters of the adult population in the United States, with 30-35% of this population having a genetic trait which predisposes these individuals to more serious forms of the disease. If patients are not properly diagnosed and treated at early stages, periodontal disease can lead to bone loss, tooth loss and implant failure. Research now suggests an increased risk to a number of systemic diseases when chronic periodontal infections are left untreated.

OralDNA offers two DNA-PCR tests for periodontal disease diagnosis and genetic susceptibility. MyPerioPath(SM) detects the presence and quantity of specific bacteria associated with periodontal disease. MyPerioID(SM) PST®, licensed through a marketing, sales and distribution agreement with Interleukin Genetics, provides a means of assessing an individual's genetic risk for periodontal disease.

The company is also developing an oral HPV test for use in assessing risks associated with oral cancer. Thereafter, OralDNA intends to develop a broader menu of clinical laboratory tests for use in oral medicine.


Contact:
Robert P. Walker
Sr. Vice President
(972) 639-6941
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->